This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Opriessnig, T.
Right arrow Articles by Meng, X. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Opriessnig, T.
Right arrow Articles by Meng, X. J.

 Previous Article  |  Next Article 

Journal of Virology, December 2002, p. 11837-11844, Vol. 76, No. 23
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.23.11837-11844.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Comparison of Molecular and Biological Characteristics of a Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine (Ingelvac PRRS MLV), the Parent Strain of the Vaccine (ATCC VR2332), ATCC VR2385, and Two Recent Field Isolates of PRRSV

T. Opriessnig,1 P. G. Halbur,1* K.-J. Yoon,1 R. M. Pogranichniy,1 K. M. Harmon,1 R. Evans,1 K. F. Key,2 F. J. Pallares,1,3 P. Thomas,1 and X. J. Meng2

Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011,1 Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061,2 Departamento de Anatomía y Anatomía Patológica Comparada, Facultad de Veterinaria, Universidad de Murcia, Murcia, Spain3

Received 12 April 2002/ Accepted 22 August 2002

The objectives of this study were to compare the molecular and biological characteristics of recent porcine reproductive and respiratory syndrome virus (PRRSV) field isolates to those of a modified live virus (MLV) PRRS vaccine and its parent strain. One hundred seventeen, 4-week-old pigs were randomly assigned to six groups. Group 1 (n = 20) served as sham-inoculated negative controls, group 2 (n = 19) was inoculated with Ingelvac PRRS MLV vaccine, group 3 (n = 20) was inoculated with the parent strain of the vaccine (ATCC VR2332), group 4 (n = 19) was inoculated with vaccine-like PRRSV field isolate 98-38803, group 5 (n = 19) was inoculated with PRRSV field isolate 98-37120, and group 6 (n = 20) was inoculated with known high-virulence PRRSV isolate ATCC VR2385. The levels of severity of gross lung lesions (0 to 100%) among the groups were significantly different at both 10 (P < 0.0001) and 28 days postinoculation (p.i.) (P = 0.002). At 10 days p.i., VR2332 (26.5% ± 4.64%) and VR2385 (36.4% ± 6.51%) induced gross lesions of significantly greater severity than 98-38803 (0.0% ± 0.0%), 98-37120 (0.8% ± 0.42%), Ingelvac PRRS MLV (0.9% ± 0.46%), and negative controls (2.3% ± 1.26%). At 28 days p.i., 98-37120 (17.2% ± 6.51%) induced gross lesions of significantly greater severity than any of the other viruses. Analyses of the microscopic-interstitial-pneumonia-lesion scores (0 to 6) revealed that VR2332 (2.9 ± 0.23) and VR2385 (3.1 ± 0.35) induced significantly more severe lesions at 10 days p.i. At 28 days p.i., VR2385 (2.5 ± 0.27), VR2332 (2.3 ± 0.21), 98-38803 (2.6 ± 0.29), and 98-37120 (3.0 ± 0.41) induced significantly more severe lesions than Ingelvac PRRS MLV (0.7 ± 0.17) and controls (0.7 ± 0.15). The molecular analyses and biological characterizations suggest that the vaccine-like isolate 98-38803 (99.5% amino acid homology based on the ORF5 gene) induces microscopic pneumonia lesions similar in type to, but different in severity and time of onset from, those observed with virulent strains VR2385 and the parent strain of the vaccine. Our data strongly suggest that isolate 98-38803 is a derivative of Ingelvac PRRS MLV and that the isolate is pneumovirulent.

* Corresponding author. Mailing address: Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine, Iowa State University, Ames, IA 50011. Phone: (515) 294-1137. Fax: (515) 294-3564. E-mail: pghalbur{at}iastate.edu.

Journal of Virology, December 2002, p. 11837-11844, Vol. 76, No. 23
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.23.11837-11844.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kim, W.-I., Kim, J.-J., Cha, S.-H., Yoon, K.-J. (2008). Different Biological Characteristics of Wild-Type Porcine Reproductive and Respiratory Syndrome Viruses and Vaccine Viruses and Identification of the Corresponding Genetic Determinants. J. Clin. Microbiol. 46: 1758-1768 [Abstract] [Full Text]  
  • Opriessnig, T., Baker, R. B., Halbur, P. G. (2007). Use of an Experimental Model To Test the Efficacy of Planned Exposure to Live Porcine Reproductive and Respiratory Syndrome Virus. CVI 14: 1572-1577 [Abstract] [Full Text]  
  • Key, K. F., Guenette, D. K., Yoon, K.-J., Halbur, P. G., Toth, T. E., Meng, X. J. (2003). Development of a Heteroduplex Mobility Assay To Identify Field Isolates of Porcine Reproductive and Respiratory Syndrome Virus with Nucleotide Sequences Closely Related to Those of Modified Live-Attenuated Vaccines. J. Clin. Microbiol. 41: 2433-2439 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»